CDK9-IN-29
Product Specifications
UNSPSC Description
CDK9-IN-29 (compound Z11) is a potent CDK9 inhibitor (IC50 = 3.20 nM) with good kinase selectivity. CDK9-IN-29 inhibits cell proliferation and induces apoptosis[1].
Target Antigen
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cdk9-in-29.html
Solubility
10 mM in DMSO
Smiles
FC1=C(C=C(C=C1)C2=C(C=NC(N3)=N2)F)OCCCCCCOC4=CC3=CC=C4C(NCCN5CCOCC5)=O
Molecular Weight
553.60
References & Citations
[1]Tizhi Wu, et al. Discovery of Selective and Potent Macrocyclic CDK9 Inhibitors for the Treatment of Osimertinib-Resistant Non-Small-Cell Lung Cancer. J Med Chem. 2023.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-149641/CDK9-IN-29-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-149641/
Clinical Information
No Development Reported
CAS Number
2737262-24-5
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
abx112663 100 µL
Gamma-Aminobutyric Acid Receptor Subunit Alpha-3 (gABRA3) Antibody
Ask
View Details 
MBS1448835-01 0.02 mg (E-Coli)
Recombinant Streptococcus thermophilus Queuine tRNA-ribosyltransferase (tgt)
Ask
View Details 
MBS1448835-02 0.02 mg (Yeast)
Recombinant Streptococcus thermophilus Queuine tRNA-ribosyltransferase (tgt)
Ask
View Details